Login/Register
India’s Third Covid Vaccine
New Delhi: India’s drug regulator, the Drugs Controller General of India, has approved the Covid vaccine Sputnik V for emergency use. Sputnik V is the third coronavirus vaccine to be approved by India’s drug regulator, as the country experiences an ongoing increase in cases. In January, the FDA approved two vaccines: Covishield from the Serum Institute of India and Covaxin from Bharat Biotech. India has been the 60th country to approve the two-dose vaccine. The Russian Direct Investment Fund (RDIF) has signed agreements with five pharmaceutical companies to produce over 850 million doses per year. However, only a few doses
Serum Institute Permits Emergency Use of ‘Covishield’, Becomes First Indian Company
Indian vaccine manufacturer Serum Institute of India (SII) has sought formal approval for the emergency use of “Covishield”, a Covid-19 vaccine from Oxford in India on 06 December 2020. According to media reports, Serum has sought permission from the Controller General of Indian Medicine (DCGI) to use the emergency of its Corona vaccine ‘Kovishield’. With this, the Serum Institute of India has become the first indigenous company in the country. Earlier, on 05 December 2020, the Indian unit of American drug maker Pfizer sought formal approval for the emergency use of the Covid-19 vaccine developed by it. Prior to this,
NDA After 10th
NDA (Offline & Online) Batch
SSB Interview (Offline & Online)
